Vaccine progress, stock prices, and the value of ending the pandemic
| Year of publication: |
2025
|
|---|---|
| Authors: | Acharya, Viral V. ; Johnson, Tim ; Sundaresan, Suresh M. ; Zheng, Steven |
| Published in: |
Management science : journal of the Institute for Operations Research and the Management Sciences. - Hanover, Md. : INFORMS, ISSN 1526-5501, ZDB-ID 2023019-9. - Vol. 71.2025, 3, p. 2714-2732
|
| Subject: | COVID-19 | regime-switching | stock prices | vaccine development | welfare costs | Börsenkurs | Share price | Coronavirus | Impfung | Vaccination | Arzneimittel | Pharmaceuticals | Wirkungsanalyse | Impact assessment |
-
On the effect of COVID-19 and policy uncertainty on the stock market : evidence from India
Adil, Masudul Hasan, (2024)
-
COVID-19 vaccinations and the volatility of energy companies in international markets
Demir, Ender, (2021)
-
Impact of COVID-19 vaccinations on UK stock market
Lu, Chengyue, (2024)
- More ...
-
The Value of a Cure : An Asset Pricing Perspective
Acharya, Viral V., (2020)
-
The Value of a Cure : An Asset Pricing Perspective
Acharya, Viral V., (2021)
-
The Value of a Cure : An Asset Pricing Perspective
Acharya, Viral V., (2021)
- More ...